Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Targeted Genetics, Sangamo combine two novel technologies for drug discovery

Jan. 19, 1999

Palatin and Nihon Medi-Physics intend to develop radiopharmaceutical products

Jan. 18, 1999

Tenth HuMAb-Mouse licensing agreement for Medarex: Immunex granted broad rights

Jan. 18, 1999

Milestone reached by Cadus in drug discovery collaboration with SmithKline Beecham

Jan. 18, 1999

Rigel and Janssen enter drug discovery collaboration

Jan. 15, 1999

Isis and Abbott establish antisense target validation partnership

Jan. 15, 1999

VP22 increases the efficacy of suicide gene therapy in vivo

Jan. 15, 1999

Telik and Cor Therapeutics enter drug screening and licensing agreement

Jan. 14, 1999

Medarex receives milestone payment from Centocor related to HuMAb-Mouse technology

Jan. 13, 1999

Key proteomics patents issued to Oxford GlycoSciences

Jan. 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...